ATA (AACG) Financials

$1.17 -0.02 (-1.68%)

Closing price 05/8/2026 04:00 PM Eastern

Extended Trading

$1.19 +0.02 (+1.97%)

As of 05/8/2026 07:55 PM Eastern

Annual Income Statements for ATA

This table shows ATA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-226	-168	-152	-40	-149
Consolidated Net Income / (Loss)	-179	-174	-157	-44	-150
Net Income / (Loss) Continuing Operations	-235	-158	-157	-44	-150
Total Pre-Tax Income	-102	-137	-135	-39	-148
Total Operating Income	-104	-136	-145	-125	-103
Total Gross Profit	0.00	20	0.23	0.31	0.31
Total Revenue	0.00	20	0.23	0.31	0.31
Operating Revenue	-	20	0.23	0.31	0.31
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	180	156	145	126	103
Selling, General & Admin Expense	81	93	70	64	48
Research & Development Expense	11	63	75	62	55
Total Other Income / (Expense), net	23	24	9.61	86	-46
Interest Expense	-	-	0.92	2.66	3.12
Interest & Investment Income	0.07	3.75	2.03	1.91	0.78
Other Income / (Expense), net	23	20	8.50	87	-43
Income Tax Expense	0.31	3.99	6.23	1.02	-0.36
Other Gains / (Losses), net	-77	-42	-16	-3.59	-2.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-8.78	-6.44	-5.03	-3.67	-0.78
Basic Earnings per Share	($1.83)	($1.21)	($0.98)	($0.25)	($0.93)
Weighted Average Basic Shares Outstanding	93.02M	138.27M	155.72M	158.83M	160.16M
Diluted Earnings per Share	($1.83)	($1.21)	($0.98)	($0.25)	($0.93)
Weighted Average Diluted Shares Outstanding	93.02M	138.27M	155.72M	158.83M	160.16M
Weighted Average Basic & Diluted Shares Outstanding	93.02M	138.27M	166.01M	166.03M	198.31M

This table shows ATA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-33	-33	44	-18	-27	-57	-26	-39	-26	-28	-61
Consolidated Net Income / (Loss)	-34	-34	43	-19	-27	-57	-26	-39	-26	-28	-61
Net Income / (Loss) Continuing Operations	-34	-34	43	-19	-27	-57	-26	-39	-26	-28	-61
Total Pre-Tax Income	-33	-32	44	-18	-26	-57	-26	-39	-26	-28	-61
Total Operating Income	-33	-32	-27	-34	-24	-26	-23	-30	-20	-25	-28
Total Gross Profit	0.04	0.17	0.09	0.02	0.00	0.27	0.04	-0.01	1.56	0.72	0.75
Total Revenue	0.04	0.17	0.09	0.02	0.00	0.27	0.04	-0.01	1.56	0.72	0.75
Operating Revenue	0.04	0.17	0.09	0.02	0.00	0.27	0.04	-0.01	1.56	0.72	0.75
Total Cost of Revenue	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Operating Expenses	33	32	27	34	24	26	23	30	22	26	29
Selling, General & Admin Expense	14	17	14	19	13	13	10	11	11	15	15
Research & Development Expense	19	15	13	14	12	13	12	19	11	11	15
Total Other Income / (Expense), net	0.06	0.20	71	15	-1.60	-31	-3.86	-8.91	-5.73	-2.38	-33
Interest Expense	0.62	0.66	0.69	0.69	0.69	0.70	0.78	0.95	0.90	1.58	0.00
Interest & Investment Income	0.28	0.30	0.61	0.72	0.31	0.12	0.16	0.19	0.19	4.04	0.50
Other Income / (Expense), net	0.41	0.56	71	15	-1.22	-31	-3.24	-8.15	-5.01	-4.84	-33
Income Tax Expense	0.17	0.19	0.24	0.43	-0.00	0.02	-0.18	-0.19	0.16	0.09	0.13
Other Gains / (Losses), net	-1.03	-1.93	-0.24	-0.39	-1.70	-0.27	-0.03	-	0.00	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.22	-0.73	-0.87	-0.85	-0.67	-0.06	-0.03	-0.03	-0.03	-0.02	-0.02
Basic Earnings per Share	($0.21)	($0.21)	$0.28	($0.11)	($0.17)	($0.36)	($0.16)	($0.24)	($0.15)	($0.14)	($0.28)
Weighted Average Basic Shares Outstanding	155.79M	155.79M	155.79M	158.83M	158.89M	160.39M	160.62M	160.16M	176.27M	196.56M	217.60M
Diluted Earnings per Share	($0.21)	($0.21)	$0.25	($0.08)	($0.17)	($0.36)	($0.16)	($0.24)	($0.15)	($0.14)	($0.28)
Weighted Average Diluted Shares Outstanding	155.79M	155.79M	177.57M	158.83M	158.89M	160.39M	160.62M	160.16M	176.27M	196.56M	217.60M
Weighted Average Basic & Diluted Shares Outstanding	166.01M	166.01M	166.01M	166.03M	167.41M	167.80M	167.80M	198.31M	200.34M	214.34M	363.19M

This table details how cash moves in and out of ATA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	67	265	-172	-146	-18
Net Cash From Operating Activities	-21	-63	-104	-84	-82
Net Cash From Continuing Operating Activities	-21	-93	-104	-84	-82
Net Income / (Loss) Continuing Operations	-179	-174	-157	-44	-150
Consolidated Net Income / (Loss)	-179	-174	-157	-44	-150
Depreciation Expense	0.02	0.05	0.17	0.32	0.47
Amortization Expense	0.06	0.20	0.13	0.37	0.52
Non-Cash Adjustments To Reconcile Net Income	152	94	51	38	24
Changes in Operating Assets and Liabilities, net	5.49	-13	1.58	-79	42
Net Cash From Investing Activities	-28	-81	-87	-53	59
Net Cash From Continuing Investing Activities	-28	-81	-87	-53	59
Purchase of Property, Plant & Equipment	-0.06	-1.13	-1.02	-0.59	-0.01
Acquisitions	-2.09	-54	-	0.00	-0.08
Purchase of Investments	-24	-26	-313	-189	-15
Divestitures	0.28	-	-	0.00	0.36
Sale and/or Maturity of Investments	0.00	0.00	227	139	82
Other Investing Activities, net	-2.48	-	0.00	-3.41	-7.75
Net Cash From Financing Activities	113	410	21	-8.36	5.37
Net Cash From Continuing Financing Activities	113	410	21	-8.36	5.37
Repayment of Debt	-	0.00	-1.75	-0.10	-0.16
Issuance of Debt	33	11	20	0.02	5.00
Other Financing Activities, net	0.12	0.94	2.29	-8.28	0.54
Effect of Exchange Rate Changes	3.17	-0.32	-1.12	0.19	0.36
Cash Interest Paid	-	0.00	0.51	1.92	2.16
Cash Income Taxes Paid	-	0.00	0.65	1.48	0.41

This table details how cash moves in and out of ATA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Change in Cash & Equivalents	-4.73	-45	-65	-31	-11	0.47	11	-17	31	3.65	-32
Net Cash From Operating Activities	-21	-23	-18	-22	-23	-16	-19	-24	-18	-14	-23
Net Cash From Continuing Operating Activities	-21	-23	-18	-22	-23	-16	-19	-24	-18	-14	-23
Net Income / (Loss) Continuing Operations	-34	-34	43	-19	-27	-57	-26	-39	-26	-28	-61
Consolidated Net Income / (Loss)	-34	-34	43	-19	-27	-57	-26	-39	-26	-28	-61
Depreciation Expense	0.07	0.08	0.07	0.10	0.08	0.08	0.08	0.23	0.22	0.23	0.23
Non-Cash Adjustments To Reconcile Net Income	11	11	8.49	8.52	7.81	7.33	6.48	2.70	4.13	-1.90	5.92
Changes in Operating Assets and Liabilities, net	2.47	0.42	-70	-12	-3.19	34	0.28	12	4.13	15	32
Net Cash From Investing Activities	16	-22	-46	-0.82	11	16	25	6.56	-11	9.78	-68
Net Cash From Continuing Investing Activities	16	-22	-46	-0.82	11	16	25	6.56	-11	9.78	-68
Purchase of Property, Plant & Equipment	-0.44	-0.13	-0.00	-0.02	-0.01	-	-0.00	-0.01	-0.27	-0.13	-0.40
Acquisitions	-	-	-	-	0.00	-	-	-	-5.75	-	-7.22
Purchase of Investments	-3.00	-40	-137	-8.72	-31	-66	87	-5.00	-5.00	-5.00	-39
Sale and/or Maturity of Investments	19	18	94	8.62	44	85	-58	11	0.00	15	-11
Other Investing Activities, net	0.00	-	-2.70	-0.71	-1.00	-2.92	-3.83	-	0.00	-	-10
Net Cash From Financing Activities	0.21	-0.10	-	-8.46	0.00	0.33	4.89	0.15	60	7.76	60
Net Cash From Continuing Financing Activities	0.21	-0.10	-	-8.46	0.00	0.33	4.89	0.15	60	7.76	60
Issuance of Common Equity	-	-	-	-	0.00	-	-	-	60	30	50
Other Financing Activities, net	0.21	-	-	-8.48	0.00	0.33	0.06	0.15	-0.17	-0.37	1.93
Effect of Exchange Rate Changes	0.16	-0.08	0.32	-0.21	-0.06	0.07	0.24	0.12	0.03	0.21	-0.47
Cash Income Taxes Paid	-	-	0.07	-	0.00	-	-0.75	0.04	0.10	0.10	-0.08

This table presents ATA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	112	414	305	293	159
Total Current Assets	100	375	287	186	80
Cash & Equivalents	97	362	191	45	18
Restricted Cash	-	-	-	0.00	10
Short-Term Investments	-	0.00	82	109	45
Note & Lease Receivable	0.23	0.91	0.00	0.51	0.00
Prepaid Expenses	2.08	12	14	5.83	7.80
Plant, Property, & Equipment, net	0.07	0.15	0.93	0.98	2.54
Total Noncurrent Assets	12	39	17	107	77
Long-Term Investments	8.04	28	6.76	1.84	42
Goodwill	-	-	-	0.00	0.33
Intangible Assets	-	-	-	1.77	3.25
Other Noncurrent Operating Assets	1.91	7.34	3.35	92	31
Total Liabilities & Shareholders' Equity	112	414	305	293	159
Total Liabilities	16	28	40	49	43
Total Current Liabilities	12	21	20	20	25
Short-Term Debt	-	0.05	0.18	0.28	6.85
Accounts Payable	3.08	6.00	2.40	4.59	2.62
Accrued Expenses	9.22	15	17	15	9.85
Other Current Liabilities	-	0.05	0.01	0.00	5.64
Total Noncurrent Liabilities	3.88	7.27	20	29	18
Long-Term Debt	1.20	0.00	15	15	14
Other Noncurrent Operating Liabilities	2.68	7.27	4.66	14	3.75
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	95	386	266	244	117
Total Preferred & Common Equity	91	377	261	243	116
Total Common Equity	91	377	261	243	116
Common Stock	275	743	793	813	835
Retained Earnings	-190	-358	-510	-551	-700
Accumulated Other Comprehensive Income / (Loss)	5.82	-8.34	-22	-19	-18
Noncontrolling Interest	4.55	9.05	5.03	1.35	0.26

This table presents ATA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	343	281	254	308	269	216	198	196	189	240
Total Current Assets	317	268	243	216	118	118	114	116	103	131
Cash & Equivalents	143	186	141	76	19	19	30	48	62	30
Restricted Cash	-	-	-	-	5.00	15	15	10	0.00	0.00
Short-Term Investments	162	64	86	133	87	69	56	50	34	84
Note & Lease Receivable	0.00	8.85	9.02	-	0.52	1.90	5.70	-	-	10
Prepaid Expenses	13	9.20	6.26	6.83	5.73	4.69	7.45	7.77	6.74	5.90
Plant, Property, & Equipment, net	0.73	1.11	1.04	0.99	0.92	0.87	0.87	2.68	2.90	3.01
Total Noncurrent Assets	24	12	9.78	91	151	97	83	77	84	106
Long-Term Investments	8.50	5.85	3.99	3.66	43	32	34	42	54	54
Goodwill	-	-	-	-	-	-	-	0.33	0.33	0.33
Intangible Assets	-	-	-	-	-	-	-	3.16	3.12	3.03
Other Noncurrent Operating Assets	8.74	4.67	4.63	76	94	65	49	32	26	49
Total Liabilities & Shareholders' Equity	343	281	254	308	269	216	198	196	189	240
Total Liabilities	47	40	38	40	46	47	51	44	45	80
Total Current Liabilities	26	20	18	20	15	18	20	29	26	17
Short-Term Debt	0.00	0.00	-	-	0.24	0.24	0.26	12	0.44	0.53
Accounts Payable	3.51	4.92	3.86	5.51	3.84	3.81	4.88	2.71	4.04	5.37
Accrued Expenses	22	14	13	13	11	13	12	8.68	15	10
Other Current Liabilities	0.26	1.22	1.21	1.18	-	0.68	2.55	5.46	6.56	0.18
Total Noncurrent Liabilities	21	20	20	20	31	30	32	15	20	63
Long-Term Debt	15	15	15	15	15	15	20	9.30	0.00	0.00
Other Noncurrent Operating Liabilities	5.60	5.34	5.16	5.06	16	14	11	5.71	20	63
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	296	241	216	269	223	169	146	152	144	160
Total Preferred & Common Equity	289	237	213	266	223	168	146	152	144	160
Total Common Equity	289	237	213	266	223	168	146	152	144	160
Common Stock	780	801	810	818	819	822	827	898	919	996
Retained Earnings	-465	-544	-577	-533	-578	-635	-661	-727	-754	-815
Accumulated Other Comprehensive Income / (Loss)	-26	-21	-21	-19	-19	-19	-20	-19	-21	-21
Noncontrolling Interest	6.68	3.82	3.09	2.24	0.71	0.64	0.60	0.22	0.19	0.16

This table displays calculated financial ratios and metrics derived from ATA's official financial filings.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	0.00%	-98.86%	34.76%	-1.91%
EBITDA Growth	0.00%	-41.52%	-17.83%	72.17%	-283.31%
EBIT Growth	0.00%	-41.66%	-17.84%	71.72%	-279.01%
NOPAT Growth	0.00%	-30.38%	-6.61%	13.34%	18.16%
Net Income Growth	0.00%	2.45%	9.66%	72.12%	-241.84%
EPS Growth	0.00%	33.88%	19.01%	74.49%	-272.00%
Operating Cash Flow Growth	0.00%	-204.57%	-65.18%	19.48%	2.00%
Free Cash Flow Firm Growth	0.00%	0.00%	-6.81%	-78.46%	104.49%
Invested Capital Growth	0.00%	53.97%	129.86%	8,535.78%	-77.66%
Revenue Q/Q Growth	0.00%	0.00%	-45.05%	-6.27%	-6.95%
EBITDA Q/Q Growth	0.00%	0.00%	-13.17%	36.40%	-16.81%
EBIT Q/Q Growth	0.00%	0.00%	-13.28%	35.96%	-16.88%
NOPAT Q/Q Growth	0.00%	0.00%	4.99%	3.09%	3.10%
Net Income Q/Q Growth	0.00%	0.00%	22.85%	38.53%	-15.25%
EPS Q/Q Growth	0.00%	0.00%	26.87%	44.44%	-20.78%
Operating Cash Flow Q/Q Growth	0.00%	-29.20%	-10.58%	9.22%	-2.91%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-16.73%	124.05%
Invested Capital Q/Q Growth	0.00%	0.00%	181.34%	46.22%	-27.94%
Profitability Metrics	-	-	-	-	-
Gross Margin	0.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	0.00%	-566.43%	-58,365.67%	-12,053.18%	-47,100.97%
Operating Margin	0.00%	-666.49%	-62,140.34%	-39,958.92%	-33,341.23%
EBIT Margin	0.00%	-567.61%	-58,493.99%	-12,272.93%	-47,421.75%
Profit (Net Income) Margin	0.00%	-855.14%	-67,560.94%	-13,979.30%	-48,717.21%
Tax Burden Percent	175.44%	127.56%	116.45%	111.73%	101.11%
Interest Burden Percent	124.71%	118.11%	99.19%	101.94%	101.61%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	-167.71%	-113.50%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-189.38%	-46.74%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	150.50%	30.34%
Return on Equity (ROE)	-187.30%	-72.40%	-48.31%	-17.21%	-83.16%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-8,887.81%	-363.13%	13.47%
Operating Return on Assets (OROA)	0.00%	-44.00%	-37.88%	-12.87%	-64.50%
Return on Assets (ROA)	0.00%	-66.29%	-43.75%	-14.66%	-66.27%
Return on Common Equity (ROCE)	-178.37%	-70.36%	-47.26%	-17.00%	-82.79%
Return on Equity Simple (ROE_SIMPLE)	-196.68%	-46.23%	-60.37%	-18.07%	-129.02%
Net Operating Profit after Tax (NOPAT)	-73	-95	-101	-88	-72
NOPAT Margin	0.00%	-466.55%	-43,498.24%	-27,971.24%	-23,338.86%
Net Nonoperating Expense Percent (NNEP)	-101.56%	-32.05%	-17.13%	21.68%	-66.75%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-33.83%	-52.26%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	455.17%	30,193.13%	20,249.04%	15,436.36%
R&D to Revenue	0.00%	311.33%	32,047.21%	19,809.87%	18,004.87%
Operating Expenses to Revenue	0.00%	766.49%	62,240.34%	40,058.92%	33,441.23%
Earnings before Interest and Taxes (EBIT)	-82	-116	-136	-39	-146
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-82	-115	-136	-38	-145
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	3.25	1.69	0.96	1.92
Price to Tangible Book Value (P/TBV)	0.00	3.25	1.69	0.97	1.98
Price to Revenue (P/Rev)	0.00	60.03	1,893.68	745.46	724.60
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	151.53	0.91	5.62
Enterprise Value to Revenue (EV/Rev)	0.00	41.33	779.77	301.45	422.11
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	15.24
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.01	0.00	0.06	0.06	0.18
Long-Term Debt to Equity	0.01	0.00	0.06	0.06	0.12
Financial Leverage	-1.09	-1.03	-1.00	-0.79	-0.65
Leverage Ratio	1.17	1.09	1.10	1.17	1.25
Compound Leverage Factor	1.46	1.29	1.10	1.20	1.28
Debt to Total Capital	1.24%	0.01%	5.44%	5.90%	15.26%
Short-Term Debt to Total Capital	0.00%	0.01%	0.06%	0.11%	4.98%
Long-Term Debt to Total Capital	1.24%	0.00%	5.38%	5.80%	10.28%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.71%	2.34%	1.79%	0.52%	0.19%
Common Equity to Total Capital	94.05%	97.64%	92.77%	93.58%	84.56%
Debt to EBITDA	-0.01	0.00	-0.11	-0.40	-0.14
Net Debt to EBITDA	1.28	3.38	1.95	3.72	0.64
Long-Term Debt to EBITDA	-0.01	0.00	-0.11	-0.40	-0.10
Debt to NOPAT	-0.02	0.00	-0.15	-0.17	-0.29
Net Debt to NOPAT	1.43	4.10	2.61	1.60	1.30
Long-Term Debt to NOPAT	-0.02	0.00	-0.15	-0.17	-0.20
Altman Z-Score	0.00	24.96	3.91	0.47	-5.63
Noncontrolling Interest Sharing Ratio	4.77%	2.82%	2.16%	1.25%	0.45%
Liquidity Ratios	-	-	-	-	-
Current Ratio	8.09	17.92	14.43	9.22	3.21
Quick Ratio	7.93	17.35	13.73	7.69	2.50
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-100	-107	-190	8.53
Operating Cash Flow to CapEx	-35,196.61%	-5,606.91%	-10,201.86%	-14,257.29%	-686,975.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-115.45	-71.60	2.73
Operating Cash Flow to Interest Expense	0.00	0.00	-113.18	-31.67	-26.39
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-114.29	-31.89	-26.39
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.08	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	185.24	0.43	0.33	0.18
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	-8.72	-4.02	1.20	104	23
Invested Capital Turnover	0.00	-3.20	-0.17	0.01	0.00
Increase / (Decrease) in Invested Capital	0.00	4.71	5.21	102	-80
Enterprise Value (EV)	0.00	842	182	95	130
Market Capitalization	0.00	1,223	441	234	223
Book Value per Share	$0.98	$2.35	$1.57	$1.46	$0.69
Tangible Book Value per Share	$0.98	$2.35	$1.57	$1.45	$0.67
Total Capital	97	386	281	260	138
Total Debt	1.20	0.05	15	15	21
Total Long-Term Debt	1.20	0.00	15	15	14
Net Debt	-104	-390	-265	-141	-93
Capital Expenditures (CapEx)	0.06	1.13	1.02	0.59	0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10.00	-8.07	-5.68	11	-10
Debt-free Net Working Capital (DFNWC)	87	354	267	166	62
Net Working Capital (NWC)	87	354	267	165	55
Net Nonoperating Expense (NNE)	106	79	56	-44	78
Net Nonoperating Obligations (NNO)	-104	-390	-265	-141	-93
Total Depreciation and Amortization (D&A)	0.09	0.24	0.30	0.69	0.99
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-39.60%	-2,438.20%	3,659.24%	-3,345.78%
Debt-free Net Working Capital to Revenue	0.00%	1,738.31%	114,775.97%	52,785.67%	20,137.99%
Net Working Capital to Revenue	0.00%	1,738.06%	114,698.71%	52,698.09%	17,913.64%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.21)	($0.98)	($0.25)	($0.93)
Adjusted Weighted Average Basic Shares Outstanding	0.00	160.71M	155.72M	158.83M	160.16M
Adjusted Diluted Earnings per Share	$0.00	($1.21)	($0.98)	($0.25)	($0.93)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	160.71M	155.72M	158.83M	160.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.21)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	138.27M	166.01M	166.03M	198.31M
Normalized Net Operating Profit after Tax (NOPAT)	-72	-95	-101	-88	-72
Normalized NOPAT Margin	0.00%	-466.55%	-43,498.24%	-27,971.24%	-23,338.86%
Pre Tax Income Margin	0.00%	-670.40%	-58,018.03%	-12,511.47%	-48,183.44%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-147.66	-14.51	-46.75
NOPAT to Interest Expense	0.00	0.00	-109.81	-33.07	-23.01
EBIT Less CapEx to Interest Expense	0.00	0.00	-148.77	-14.73	-46.76
NOPAT Less CapEx to Interest Expense	0.00	0.00	-110.92	-33.29	-23.01
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.74%	-7.09%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from ATA's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	1.18%	262.50%	-53.85%	-100.00%	58.72%	-54.02%	-127.78%	0.00%	163.37%	1,772.50%
EBITDA Growth	-2.20%	-0.47%	232.64%	54.41%	23.09%	-80.88%	-158.12%	-109.48%	0.41%	46.97%	-139.74%
EBIT Growth	-2.47%	-0.96%	231.98%	54.12%	22.88%	-80.47%	-158.83%	-109.45%	-0.32%	46.69%	-138.66%
NOPAT Growth	0.68%	9.88%	0.77%	10.66%	27.49%	19.25%	40.72%	9.79%	15.42%	1.77%	-25.81%
Net Income Growth	8.53%	9.97%	221.48%	58.97%	20.31%	-69.88%	-160.67%	-103.70%	3.33%	51.64%	-132.21%
EPS Growth	12.50%	12.50%	213.64%	71.43%	19.05%	-71.43%	-164.00%	-200.00%	11.76%	61.11%	-75.00%
Operating Cash Flow Growth	11.99%	-3.11%	34.28%	28.01%	-6.93%	28.24%	-4.94%	-10.62%	20.96%	13.15%	-20.27%
Free Cash Flow Firm Growth	0.56%	28.67%	-250.49%	-299.36%	-340.95%	-186.67%	123.13%	147.06%	146.65%	153.69%	-11.33%
Invested Capital Growth	-82.14%	54.30%	4,904.27%	8,535.78%	27,795.10%	5,036.71%	-54.68%	-77.66%	-72.93%	-111.45%	-125.28%
Revenue Q/Q Growth	-5.13%	364.86%	-49.42%	-79.31%	-100.00%	0.00%	-85.35%	-112.50%	31,200.00%	-53.76%	4.17%
EBITDA Q/Q Growth	17.94%	4.68%	241.63%	-141.15%	-38.43%	-124.18%	54.49%	-48.33%	34.18%	-19.35%	-105.75%
EBIT Q/Q Growth	17.95%	4.59%	240.31%	-141.77%	-37.91%	-123.28%	54.26%	-48.70%	33.94%	-18.64%	-104.79%
NOPAT Q/Q Growth	11.58%	4.07%	-19.66%	11.97%	28.24%	-6.83%	12.15%	-33.95%	32.72%	-24.07%	-12.52%
Net Income Q/Q Growth	26.36%	1.70%	228.43%	-144.13%	-43.03%	-109.54%	54.14%	-48.19%	32.13%	-4.84%	-120.20%
EPS Q/Q Growth	25.00%	0.00%	219.05%	-132.00%	-112.50%	-111.76%	55.56%	-50.00%	37.50%	6.67%	-100.00%
Operating Cash Flow Q/Q Growth	30.80%	-7.12%	18.50%	-19.16%	-2.78%	28.11%	-19.18%	-25.61%	26.57%	21.00%	-65.04%
Free Cash Flow Firm Q/Q Growth	26.65%	-1.53%	-321.80%	-27.14%	19.01%	33.99%	134.04%	158.64%	-19.72%	-24.03%	-43.78%
Invested Capital Q/Q Growth	-125.52%	-219.61%	7,340.80%	46.22%	-18.15%	-43.03%	-33.52%	-27.94%	-0.80%	-124.09%	-46.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	0.00%	100.00%	100.00%	0.00%	100.00%	100.00%	100.00%
EBITDA Margin	-88,275.68%	-18,100.58%	50,682.76%	-100,811.11%	0.00%	-20,627.47%	-64,065.00%	0.00%	-1,608.87%	-4,152.99%	-8,202.54%
Operating Margin	-89,767.57%	-18,524.42%	-30,843.68%	-186,450.00%	0.00%	-9,424.54%	-56,505.00%	0.00%	-1,309.97%	-3,515.02%	-3,796.53%
EBIT Margin	-88,672.97%	-18,199.42%	50,483.91%	-101,922.22%	0.00%	-20,693.41%	-64,600.00%	0.00%	-1,632.35%	-4,188.32%	-8,233.64%
Profit (Net Income) Margin	-92,848.65%	-19,634.30%	49,851.72%	-106,338.89%	0.00%	-21,014.29%	-65,777.50%	0.00%	-1,701.93%	-3,858.97%	-8,157.28%
Tax Burden Percent	103.61%	106.67%	98.91%	104.49%	106.61%	100.51%	99.43%	99.51%	100.59%	100.34%	100.21%
Interest Burden Percent	101.06%	101.13%	99.83%	99.85%	101.50%	101.03%	102.41%	101.98%	103.65%	91.83%	98.86%
Effective Tax Rate	0.00%	0.00%	0.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-296.41%	-782.53%	0.00%	-105.44%	-254.44%	0.00%	-31.73%	-265.77%	-668.85%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-324.70%	-784.67%	0.00%	-82.07%	-247.71%	0.00%	-22.61%	-258.32%	-639.66%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	284.82%	623.55%	0.00%	71.96%	186.26%	0.00%	16.13%	222.97%	589.57%
Return on Equity (ROE)	-51.84%	-56.17%	-11.59%	-158.98%	0.00%	-33.47%	-68.18%	0.00%	-15.60%	-42.80%	-79.29%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-230.07%	-363.13%	-196.46%	-261.81%	-68.92%	13.47%	-13.89%	0.00%	0.00%
Operating Return on Assets (OROA)	-72.06%	-16.43%	51.97%	-106.87%	0.00%	-33.33%	-84.56%	0.00%	-13.08%	-47.76%	-113.64%
Return on Assets (ROA)	-75.46%	-17.73%	51.32%	-111.50%	0.00%	-33.85%	-86.10%	0.00%	-13.64%	-44.00%	-112.58%
Return on Common Equity (ROCE)	-50.78%	-54.96%	-11.40%	-156.99%	0.00%	-33.15%	-67.71%	0.00%	-15.56%	-42.69%	-79.09%
Return on Equity Simple (ROE_SIMPLE)	-65.12%	-70.80%	-26.82%	0.00%	-16.59%	-36.05%	-89.35%	0.00%	-98.08%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-23	-22	-27	-23	-17	-18	-16	-21	-14	-18	-20
NOPAT Margin	-62,837.30%	-12,967.09%	-30,676.26%	-130,515.00%	0.00%	-6,597.18%	-39,553.50%	0.00%	-916.98%	-2,460.51%	-2,657.57%
Net Nonoperating Expense Percent (NNEP)	-3.73%	-4.26%	28.29%	2.15%	-5.54%	-23.37%	-6.73%	-15.20%	-9.11%	-7.46%	-29.19%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-9.05%	-7.06%	-	-	-15.41%	-8.23%	-12.25%	-12.41%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	37,756.76%	9,626.74%	15,667.82%	107,905.56%	0.00%	4,907.33%	25,662.50%	0.00%	681.48%	2,072.32%	1,936.58%
R&D to Revenue	52,110.81%	8,997.67%	15,275.86%	78,644.44%	0.00%	4,617.22%	30,942.50%	0.00%	728.49%	1,542.70%	1,959.95%
Operating Expenses to Revenue	89,867.57%	18,624.42%	30,943.68%	186,550.00%	0.00%	9,524.54%	56,605.00%	0.00%	1,409.97%	3,615.02%	3,896.53%
Earnings before Interest and Taxes (EBIT)	-33	-31	44	-18	-25	-56	-26	-38	-25	-30	-62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-33	-31	44	-18	-25	-56	-26	-38	-25	-30	-61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.27	1.34	0.80	0.96	1.47	1.33	1.34	1.92	1.77	3.05	7.10
Price to Tangible Book Value (P/TBV)	1.27	1.34	0.80	0.97	1.47	1.33	1.34	1.98	1.82	3.13	7.25
Price to Revenue (P/Rev)	1,112.89	1,049.77	639.26	745.46	1,180.77	589.02	588.06	724.60	144.76	190.01	375.70
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.26	0.91	2.23	2.13	2.52	5.62	6.13	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	234.62	264.74	55.80	301.45	683.30	272.60	244.78	422.11	75.46	125.37	320.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.24	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.07	0.06	0.06	0.07	0.09	0.14	0.18	0.14	0.00	0.00
Long-Term Debt to Equity	0.06	0.07	0.06	0.06	0.07	0.09	0.14	0.12	0.06	0.00	0.00
Financial Leverage	-1.00	-1.01	-0.88	-0.79	-0.82	-0.88	-0.75	-0.65	-0.71	-0.86	-0.92
Leverage Ratio	1.12	1.12	1.15	1.17	1.19	1.22	1.22	1.25	1.24	1.30	1.43
Compound Leverage Factor	1.13	1.14	1.15	1.17	1.20	1.23	1.25	1.28	1.28	1.19	1.41
Debt to Total Capital	5.79%	6.45%	5.28%	5.90%	6.51%	8.41%	12.34%	15.26%	12.10%	0.30%	0.33%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.11%	0.10%	0.13%	0.15%	4.98%	6.73%	0.30%	0.33%
Long-Term Debt to Total Capital	5.79%	6.45%	5.28%	5.80%	6.41%	8.28%	12.18%	10.28%	5.37%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.49%	1.34%	0.79%	0.52%	0.30%	0.35%	0.36%	0.19%	0.13%	0.13%	0.10%
Common Equity to Total Capital	92.72%	92.21%	93.94%	93.58%	93.19%	91.24%	87.31%	84.56%	87.78%	99.57%	99.57%
Debt to EBITDA	-0.11	-0.11	-0.25	-0.40	-0.51	-0.28	-0.17	-0.14	-0.14	0.00	0.00
Net Debt to EBITDA	1.76	1.58	3.32	3.72	4.57	2.21	0.92	0.64	0.89	1.26	1.09
Long-Term Debt to EBITDA	-0.11	-0.11	-0.25	-0.40	-0.50	-0.28	-0.16	-0.10	-0.06	0.00	0.00
Debt to NOPAT	-0.15	-0.15	-0.17	-0.17	-0.19	-0.20	-0.28	-0.29	-0.30	-0.01	-0.01
Net Debt to NOPAT	2.38	2.19	2.18	1.60	1.70	1.56	1.54	1.30	1.87	2.17	2.30
Long-Term Debt to NOPAT	-0.15	-0.15	-0.17	-0.17	-0.19	-0.20	-0.27	-0.20	-0.13	0.00	0.00
Altman Z-Score	2.46	1.99	2.05	0.70	1.42	-1.60	-2.26	-3.40	-1.36	0.21	3.49
Noncontrolling Interest Sharing Ratio	2.04%	2.15%	1.58%	1.25%	0.00%	0.97%	0.68%	0.00%	0.25%	0.27%	0.25%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	13.43	13.54	10.96	9.22	7.83	6.68	5.81	3.21	4.07	4.02	7.90
Quick Ratio	12.97	13.19	10.61	7.69	7.11	5.11	4.66	2.50	3.45	3.76	7.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-23	-23	-99	-126	-102	-67	23	59	48	36	20
Operating Cash Flow to CapEx	-4,765.46%	-17,667.19%	-921,550.00%	-129,188.24%	-451,460.00%	0.00%	-1,934,100.00%	-404,916.67%	-6,657.09%	-11,097.64%	-5,873.99%
Free Cash Flow to Firm to Interest Expense	-37.16	-35.66	-144.28	-182.37	-148.34	-95.83	29.24	62.21	52.83	22.85	0.00
Operating Cash Flow to Interest Expense	-33.94	-34.37	-26.87	-31.83	-32.86	-23.12	-24.70	-25.52	-19.82	-8.91	0.00
Operating Cash Flow Less CapEx to Interest Expense	-34.65	-34.56	-26.87	-31.85	-32.86	-23.12	-24.70	-25.53	-20.12	-8.99	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.42	0.40	0.39	0.33	0.27	0.39	0.36	0.18	1.03	1.22	1.56
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-0.31	-0.98	71	104	85	48	32	23	23	-5.53	-8.11
Invested Capital Turnover	-1.14	-0.17	0.01	0.01	0.01	0.02	0.01	0.00	0.03	0.11	0.25
Increase / (Decrease) in Invested Capital	-0.14	1.16	72	102	85	49	-39	-80	-62	-54	-40
Enterprise Value (EV)	63	72	19	95	189	103	81	130	141	289	966
Market Capitalization	300	286	214	234	327	223	195	223	270	439	1,134
Book Value per Share	$1.43	$1.28	$1.60	$1.46	$1.34	$1.00	$0.87	$0.69	$0.77	$0.72	$0.75
Tangible Book Value per Share	$1.43	$1.28	$1.60	$1.45	$1.34	$1.00	$0.87	$0.67	$0.75	$0.70	$0.73
Total Capital	255	231	283	260	239	184	167	138	173	144	160
Total Debt	15	15	15	15	16	15	21	21	21	0.44	0.53
Total Long-Term Debt	15	15	15	15	15	15	20	14	9.30	0.00	0.00
Net Debt	-241	-217	-198	-141	-139	-120	-114	-93	-129	-149	-168
Capital Expenditures (CapEx)	0.44	0.13	0.00	0.02	0.01	0.00	0.00	0.01	0.27	0.13	0.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.90	-2.65	-13	11	-8.52	-2.84	-6.23	-10	-9.07	-18	0.05
Debt-free Net Working Capital (DFNWC)	248	225	196	166	103	101	95	62	99	78	115
Net Working Capital (NWC)	248	225	196	165	102	100	94	55	87	77	114
Net Nonoperating Expense (NNE)	11	11	-70	-4.35	11	39	10	18	12	10	41
Net Nonoperating Obligations (NNO)	-241	-217	-198	-141	-139	-120	-114	-93	-129	-149	-168
Total Depreciation and Amortization (D&A)	0.15	0.17	0.17	0.20	0.18	0.18	0.21	0.41	0.37	0.25	0.23
Debt-free, Cash-free Net Working Capital to Revenue	-704.81%	-973.53%	-3,840.00%	3,659.24%	-3,074.01%	-752.12%	-1,882.78%	-3,345.78%	-487.06%	-795.67%	1.59%
Debt-free Net Working Capital to Revenue	91,844.44%	82,663.24%	58,546.27%	52,785.67%	37,087.00%	26,588.10%	28,606.65%	20,137.99%	5,320.99%	3,359.51%	3,799.01%
Net Working Capital to Revenue	91,844.44%	82,663.24%	58,546.27%	52,698.09%	36,998.92%	26,524.87%	28,529.00%	17,913.64%	4,695.49%	3,340.58%	3,781.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.21)	($0.21)	$0.28	($0.11)	($0.17)	($0.36)	($0.16)	($0.24)	($0.15)	($0.14)	($0.28)
Adjusted Weighted Average Basic Shares Outstanding	155.79M	155.79M	155.79M	158.83M	158.89M	160.39M	160.62M	160.16M	176.27M	196.56M	217.60M
Adjusted Diluted Earnings per Share	($0.21)	($0.21)	$0.25	($0.08)	($0.17)	($0.36)	($0.16)	($0.24)	($0.15)	($0.14)	($0.28)
Adjusted Weighted Average Diluted Shares Outstanding	155.79M	155.79M	177.57M	158.83M	158.89M	160.39M	160.62M	160.16M	176.27M	196.56M	217.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	166.01M	166.01M	166.01M	166.03M	167.41M	167.80M	167.80M	198.31M	200.34M	214.34M	363.19M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-22	-27	-23	-17	-18	-16	-21	-14	-18	-20
Normalized NOPAT Margin	-62,837.30%	-12,967.09%	-30,676.26%	-130,515.00%	0.00%	-6,597.18%	-39,553.50%	0.00%	-916.98%	-2,460.51%	-2,657.57%
Pre Tax Income Margin	-89,610.81%	-18,405.81%	50,398.85%	-101,772.22%	0.00%	-20,907.33%	-66,157.50%	0.00%	-1,691.90%	-3,846.04%	-8,139.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-52.75	-47.57	64.02	-26.59	-36.83	-80.47	-33.00	-40.36	-28.20	-19.05	0.00
NOPAT to Interest Expense	-37.38	-33.90	-38.90	-34.05	-24.54	-25.66	-20.21	-22.26	-15.84	-11.19	0.00
EBIT Less CapEx to Interest Expense	-53.46	-47.77	64.02	-26.61	-36.84	-80.47	-33.00	-40.37	-28.50	-19.13	0.00
NOPAT Less CapEx to Interest Expense	-38.09	-34.09	-38.91	-34.07	-24.55	-25.66	-20.21	-22.27	-16.14	-11.27	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

ATAI Life Sciences N.V. (NASDAQ: ATAI) has reported quarterly figures across the last several years. The company continues to operate as a pre-revenue biotech with negative cash flow from operations, but the 2025 third quarter shows a notable liquidity boost driven by equity financing. Here are the top takeaways for retail investors:

Strong liquidity: cash and short-term investments total about $114.6 million as of 9/30/2025 (cash $30.4M + short-term investments $84.2M).
Equity financing strengthened the balance sheet: common equity issuance of about $49.95 million in Q3 2025.
Financing activities yielded a net cash inflow of about $59.74 million in Q3 2025, helping fund operations during continued cash burn.
Total equity rose to about $159.9 million by 9/30/2025, up from prior periods due to the equity raise.
Revenue remains minimal (Q3 2025 revenue around $0.75 million), reflecting ATAI's pre-revenue biotech stage.
Long-term debt remained at zero in Q3 2025, indicating no debt burden on the balance sheet.
Total assets stood at roughly $239.8 million at 9/30/2025, reflecting a larger asset base from liquidity and equity proceeds.
Net income (continuing operations) was a substantial loss in Q3 2025: about $61.1 million.
Operating cash flow remained negative in Q3 2025: about $23.3 million used.
Investing cash flow was heavily negative in Q3 2025: about $67.6 million used for investing activities.

Bottom line: ATAI’s near-term liquidity has improved thanks to financing activities, but the company continues to burn cash with limited revenue to-date. Keep an eye on future financing events and clinical milestones for signs of runway extension and potential path to profitability.

05/09/26 08:36 AM ETAI Generated. May Contain Errors.

ATA Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ATA's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

ATA's net income appears to be on a downward trend, with a most recent value of -$150.05 million in 2024, falling from -$178.63 million in 2020. The previous period was -$43.90 million in 2023. Check out ATA's forecast to explore projected trends and price targets.

ATA's total operating income in 2024 was -$102.69 million, based on the following breakdown:

Total Gross Profit: $308 thousand
Total Operating Expenses: $103.00 million

Over the last 4 years, ATA's total revenue changed from $0.00 in 2020 to $308 thousand in 2024, a change of 30,800,000.0%.

ATA's total liabilities were at $42.83 million at the end of 2024, a 12.9% decrease from 2023, and a 164.7% increase since 2020.

In the past 4 years, ATA's cash and equivalents has ranged from $17.51 million in 2024 to $362.27 million in 2021, and is currently $17.51 million as of their latest financial filing in 2024.

Over the last 4 years, ATA's book value per share changed from 0.98 in 2020 to 0.69 in 2024, a change of -29.0%.

Related Companies

Financial statements for NASDAQ:AACG last updated on 11/14/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ATA (AACG) Financials

Financials Breakdown Chart

Key Financial Trends

ATA Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ATA (AACG) Financials

Annual Income Statements for ATA

Quarterly Income Statements for ATA

Annual Cash Flow Statements for ATA

Quarterly Cash Flow Statements for ATA

Annual Balance Sheets for ATA

Quarterly Balance Sheets for ATA

Annual Metrics And Ratios for ATA

Quarterly Metrics And Ratios for ATA

Financials Breakdown Chart

Key Financial Trends

ATA Financials - Frequently Asked Questions

When does ATA's financial year end?

How has ATA's net income changed over the last 4 years?

What is ATA's operating income?

How has ATA's revenue changed over the last 4 years?

How much debt does ATA have?

How much cash does ATA have?

How has ATA's book value per share changed over the last 4 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools